Elizabeth Varki Jobes, Esq., was appointed senior vice president, chief compliance officer North America, EMD Serono, the biopharmaceutical business of Merck KGaA. Ms. Jobes will oversee the strategic direction of EMD Serono’s comprehensive compliance program. She will serve as a member of EMD Serono’s leadership team, as well as a member of the Global Compliance Healthcare team led by Betania Glorio, global compliance officer, Healthcare, Merck KGaA, Darmstadt, Germany.

“It’s an exciting time to be at EMD Serono as we prepare to introduce new therapies into practice and advance existing standards of care,” said Rehan Verjee, president of EMD Serono and global head of Innovative Medicine Franchises, Merck KGaA, Darmstadt, Germany. “I am very pleased to welcome Elizabeth at this time given her significant experience in supporting companies like ours achieve on this mission.”

Prior to joining EMD Serono, Ms. Jobes served as global chief compliance officer and Legal Counsel at Spark Therapeutics, Inc., where she was responsible for building a corporate compliance program supporting the launch of the first-approved gene therapy in the U.S.

Previously, Ms. Jobes held leadership positions across a number of biopharmaceutical companies, including senior vice president, chief compliance officer for Auxilium Pharmaceuticals, Inc.; vice president, chief compliance officer for Adolor (Cubist) Corp.; and senior director, Global Compliance for Cephalon, Inc.